Autologous peptide-induced active immunity

Autologous peptide-induced active immunity · Fujian Medical University Union Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous peptide-induced active immunity, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy [Phase 1]